Ta Yaya Zaku iya Sarrafa Tarraya (Erlotinib) Matsalolin Lakaran Da Suka shafi?

Skin Rash da sauran cututtuka saboda Tarbava (Erlotinib)

Idan ka taba samun raguwa, kamar busar fata, ƙyamar, da gyaran ƙusa yayin shan Tarceva (erlotinib) ba kai kadai ba ne. Ga wasu mutanen da ke fama da ciwon huhu na huhu, da Targeva Tarurruka (erlotinib,) da kuma sauran masu cin zarafin mai karfin rashawa (EGFR), sun zama magungunan ƙwayoyi don hanyar mutanen da ke fama da ciwon huhu na EGFR. Wadannan jiyya sun inganta rayuwa mai kyau yayin da suke rayuwa tare da ciwon daji, rayuwa, kuma sau da yawa tare da raguwar sakamako fiye da ilimin likitanci .

Ɗaya daga cikin sakamako na gaba, duk da haka, an samu mai yawa hankali: matsalolin fata

Mafi yawan mutanen da ke amfani da maganin Tardeva (da sauran masu cin zarafi na EGFR) suna ci gaba da raguwa, kuma sha'awa, bayyanar raguwa an daidaita ta tare da amsa ga miyagun ƙwayoyi. Tun da yake ana amfani da wannan magani na tsawon lokaci, yana da mahimmanci a tattauna yadda za a gudanar da duk wani mummunan alamu da likitan ka.

(Idan kana da ciwo na huhu, musamman adenocarcinoma, tabbatar da cewa likitanku ya yi gwajin kwayoyin (wallafe-wallafen kwayoyin) .

Waɗanne Rashin La'ani na Lafiya Kasuwanci ne da Tarbeva (Erlotinib)?

Kullum mutane masu fama da fata suna jin dadi akan Tarceva (da kuma sauran masu haɓakawa na epidermal factor inhibitors) sun hada da:

Ta Yaya Saurin Ƙarƙashin Kasa?

Yawancin mutanen da ke kula da magunguna kamar Tarceva suna da mummunan fata, mafi yawan irin rash wanda yayi kama da kuraje, da kuma fata bushe.

Rashin Immalar La'ani na Lafiya na Tarbeva

Matsalar cututtuka a kan ci gaban haɓaka mai cike da ƙwayar cuta mai karfin gaske zai iya tasiri sosai ga rayuwar mutum da kuma tunanin rai ga mutanen da ke shan wadannan magunguna.

Ɗaya daga cikin binciken ya gano cewa wadannan cututtuka masu illa sun shafi lafiyar jiki, aiki, da tausayi, da zamantakewa na marasa lafiya a kan kwayoyi. Abun hankalin da ya fi dacewa shine game da bayyanar cututtukan jiki, ciki har da ciwo, jin dadi, da farinciki.

Yaushe ne Rash yake faruwa da tsawon tsawon lokacin?

Skin rashes a kan Tarceva yawanci fara zuwa makonni biyu bayan da aka fara maganin, suna cikin mummunan makonni 2 zuwa 3 bayan an fara farawa, kuma zai iya yanke shawara a hankali ko ƙare gaba daya a cikin watanni 2 zuwa 3 na gaba. Sanin cewa rash yayi kokarin inganta a tsawon lokaci ya taimaka wa wasu mutane su magance alamun.

Shin Rashin Ma'anar Tarba Ne Yana Aiki Mafi Girma?

Nazarin ya nuna cewa mutanen da suke ci gaba da raguwa a kan miyagun ƙwayoyi suna da kyakkyawar amsawa kuma mafi kyau duka rayuwa. Saboda wannan, kuma saboda ana amfani da miyagun ƙwayoyi na tsawon lokaci, yana da mahimmanci a yi aiki a cikin maganin bayyanar cututtuka na gaggawa.

Matsarar cututtukan da suka danganci sauran ciwon daji irin su chemotherapy da radiationrapy na iya zama tare tare da wadanda daga Tarceva kuma ya kamata a magance su da hankali daga likitanku.

Girma na Rash

Rashin raguwa na ƙwayoyi irin na Tarceva yawanci an rushe su cikin sassa uku:

Ta Yaya Yaya Kasusuwan Ƙarke Daga Cikin Tarba?

Ta yaya za a bike ku da sauri a kan mummunar raguwa, da kuma abubuwan da kuke so. Ko da yake rash yayi kama da kuraje, ba ƙyama ba ne, kuma ba zai amsa yawan jiyya ba.

Tarceva (Erlotinib) Rash Prevention da Daily Care

Mataki na farko a gudanarwa shi ne rigakafi: Tsarin hanzari ya haɗa da kiyaye tsabta fata, kauce wa kunar rana, da kuma amfani da moisturizers don kiyaye jikinka hydrated. Hanya mafi kyau don guje wa ƙutar rana shine don kauce wa hasken rana kai tsaye a tsakiyar rana, da kuma yin amfani da tufafi masu tsaro, kamar yadda sunscreens da kuma musamman sutura na iya sanya rashes mai raguwa. Cutar da raguwa tare da samfurori na vaseline zai iya yin haɗari gashi gashi da kuma ciwo da gaggawa. (Bincika waɗannan shawarwari kan kiyaye lafiyar rana a yayin da ake shan magani .)

Yana da mahimmanci a lura da cewa jiyya na daya daga cikin alamu da suka danganci Tarceva na iya kara tsananta wani alama kuma za a gani. Alal misali, masu shayarwa zasu iya taimakawa tare da bushewa da kuma itching amma suna ciwo da ƙwayar kura.

Tarceva (Erlotinib) Rash Jiyya

Jiyya na gaggawa gaggawa yana dogara ne akan ko cutar ta kamu ko a'a, kuma zai iya haɗawa da magance matsalar gaggawa, ko kuma daidaita tsarin. Waɗannan zaɓuɓɓuka sun haɗa da:

Jiyya iri:

Jiyya na Rash Alone: Idan bayyanar cututtuka sun hada da ja rash kadai ba tare da alamun kamuwa da cutar ba, ana bi da shi tare da steroids masu tasowa, 1% hydrocortisone, ko 2.5% idan rash ne mai tsanani. A wannan yanayin, akwai jawa amma babu fararen fararen da zai nuna cewa kamuwa da cuta ne.

Jiyya na Rash Infected Rash: A lokacin da rash na Tarbava ya rikitarwa ta hanyar kamuwa da kwayar cutar ta biyu ba wai kawai jawa ba amma yawanci alamun kamuwa da kamuwa da cutar irin su whiteheads. Idan wannan ya faru, magani ya hada da maganin maganin rigakafi (tetracyclines) tare da gel-gel clindamycin.

Shirye-shiryen magancewa : Kusan kashi 10 cikin dari na mutane suna ci gaba da raguwa wanda ke buƙatar canjin magani. Yanayin "saba" na Tarceva yana da miliyon 150 a kowace rana. Kwararren likitanku na iya la'akari da ragewan wannan kashi zuwa 100 MG ko ma 50 mg kowace rana. Wannan na iya zama tsoratarwa, musamman idan magani yana aiki sosai a gare ku. Yana iya taimakawa wajen fahimtar cewa ko da ƙananan ciwon Tarceva, kamar yadda ya kai 25 mg kowace rana, sun sami tasiri a zalunta wasu mutane da ciwon huhu na huhu.

> Sources:

> Cibiyar Nazarin Harkokin Kwayoyi ta Amirka. Cancer.net Ra'ayoyin Lafiya ga Ra'ayoyin Dabaru. Samun shiga 05/2016. http://www.cancer.net/navigating-cancer-care/side-effects/skin-reactions-targeted-therapy-and-immunotherapy

> Burotto, M., Manasanch, E., Wilkerson, J., da T. Fojo. Gefitinib da erlotinib a cikin kwayar cutar marasa ciwon ƙananan ƙwayar cutar kwayar halitta: wani zane-zane na rashin illa da kuma ingancin gwaji na asibiti. Oncologist . 2015. 20 (4): 400-10.

> Califano, R. et al. Kwararren Masana kan Gudanar da Ayyukan Kira daga EGFR Tyrosine Kinase Inhibitors a Birtaniya. Drugs . 2015. 75 (12): 1335-48.

> Fabbrocini, G., Panariello, L., Caro, G., da kuma S. Cacciapuoti. Acneiform Rash Ƙaddamar da Masu Shawarar EGFR: Binciken Wallafe-wallafe da Sabon Alkawari .. Cutar Laya na Skin . 2015. 1: 31-37.

> Hwang, I. et al. Phase II gwaji na epidermal girma factor maganin shafawa ga marasa lafiya tare da Erlotinib-related effects fata. Taimakon tallafi a Ciwon daji . 2015 Yuni 4. (Epub gaba da bugu).

> Kiyohara, Y., Yamazaki, N., da kuma A. Kishi. Abubuwan da ke da alaka da cututtukan fata na Erlotinib: hanyoyin magance magungunan marasa lafiya da kwayar cutar marasa ciwon ƙwayar cuta. Journal of the American Academy of Dermatology . 2013. 69 (3): 463-72.

> Ocvirk, J., Heeger, S., McCloud, P., da R. Hofheinz. Binciken da za a yi don maganin zafin jiki na gaggawa ta hanyar EGFR-magance hanyoyin kwantar da hankali: Shaida daga gwaji na asibitoci da kuma nazari na meta. Radiology da Oncology . 2013. 47 (2): 166-75.

> Passaro, A. et al. Gudanar da ƙananan abubuwan da ba su dacewa da juna ba dangane da daban-daban na EGFR-TKIs a cikin NSCLC ci-gaba: kwatanta kwatanta. Clinic Lung Cancer . 2014. 15 (4): 307-12.

> Shinohara, A. et al. Amfani da maganin maganin minocycline na prophylactic don maganin cututtukan fata wanda ya haifar da erlotinib tare da gemcitabine a cikin marasa lafiya tare da ciwon ciwon daji na ciwon sukari mai girma: nazarin nazari. American Journal of Clinical Dermatology . 2015. 16 (3): 221-9.

> Szejiniuk, W., McCullock, T., da kuma O. Roe. Hanyoyin ƙananan ƙananan ƙwayoyin cuta a cikin marasa lafiya tare da EGFR sanadiyar maye gurbin. BMJ Case Reports . 2014. Doi: 10.1136 / bcr-2014-204809.